| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Barry B Bondroff last filed a Form 4 in June 2015, as Director at MED. Barry B Bondroff's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 14,533 shares of MED. The MED filings lean toward selling, a net 12,379 shares.
Barry B Bondroff has 4 Form 4 filings on record from February 2015 to June 2015, all as Director at Medifast (MED), 2015.
The 6 reported transactions were 3 open-market sales, 1 option exercise, 1 stock award and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $404K.
The largest open-market sale was 10,713 shares of MED at an average $32.71 on June 2, 2015, about $350K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.